This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Align Technology Expands Clear Aligner Research Award Program To Include International Funding

SAN JOSE, Calif., Dec. 8, 2010 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN) today announced that it has expanded its funding of the Clear Aligner Research Award Program to include international research in order to further the development of clear aligners for the treatment of malocclusion, or misalignment of teeth worldwide. Launched initially in 2009 for North America, the Clear Aligner Research Award Program is an annually funded program designed to promote both clinical and scientific research in clear aligner therapy.  For 2011, $50,000 is now being made available for scientific research funding to international applicants in addition to $100,000 currently available to North American applicants.

"We are excited to extend the research program in support of greater academic understanding and advancement of clear aligner therapy around the world," said Align's Vice President of Clinical Technology, Eric Kuo, DDS, MS.

International eligibility includes without limitation full-time or part-time international university faculty involved in orthodontic scientific research, as well as non-orthodontic international university faculty whose scientific work may contribute towards the improvement of clear aligner therapy.  Up to five grants of $10,000 each will be made available to qualified international orthodontic faculty.

"Increased international adoption of clear aligner orthodontic treatment has driven interest in improving our understanding of the scientific processes behind the therapy," said Align's Director of Clinical International, Mitra Derakhshan, DDS, MS. "Through this program, further insights into complex treatments, individual tooth movements and outcomes for treatment using clear aligners can be gained.

Applications for International funding can be downloaded from www.aligntechinstitute.com/internationalresearch . Completed applications must be e-mailed to InternationalResearch@aligntech.com by 5PM PST March 1, 2011.  All applications will be reviewed by an academic committee and their recommendations will be forwarded to Align Technology. Final selections will be made by Align Technology. All applicants will be notified by April 29, 2011. Incomplete applications will not be considered.  For more information on the Clear Aligner Research Award Program and application process for International, please visit www.aligntechinstitute.com/internationalresearch or email InternationalResearch@aligntech.com. 

For information on the Clear Aligner Research Award Program and application process for North America, please visit www.aligntechinstitute.com/ResearchAwards or email ResearchAwards@aligntech.com.  Completed applications for North American funding in 2011 must be e-mailed to ResearchAwards@aligntech.com by 5PM PST March 1, 2011.

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign(R), a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998. Today, Invisalign is a globally-recognized brand, with treatment available through specially-trained doctors in more than 50 countries. The Invisalign product family now includes Invisalign Full, Invisalign Teen, Invisalign Assist, Invisalign Lite, Invisalign Express, Invisalign Anterior, and Vivera Retainers.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,083.80 -2.83 -0.02%
S&P 500 1,987.98 +0.97 0.05%
NASDAQ 4,472.1080 -1.5890 -0.04%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs